European Union approves Novavax coronavirus vaccine

The European Union has authorized the use of the Novavax COVID-19 vaccine. Manufactured in the United States, Novavax's two-dose vaccine will be the fifth coronavirus vaccine approved by the European Union. For now the EU has ordered around 100 million doses of the vaccine.